Jazz Pharmaceuticals plc Earnings Per Share Diluted

• Jazz Pharmaceuticals plc showed a decrease of -167.5% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Jazz Pharmaceuticals plc's annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), Jazz Pharmaceuticals plc's Earnings Per Share Diluted has declined by 2,439.1%.
• Historical annual values: Fiscal year 2025: $5.84 (loss) per share | Fiscal year 2024: $8.65 per share | Fiscal year 2023: $6.10 per share | Fiscal year 2022: $3.58 (loss) per share | Fiscal year 2021: $5.52 (loss) per share | Fiscal year 2020: $4.22 per share | Fiscal year 2019: $9.09 per share | Fiscal year 2018: $7.30 per share | Fiscal year 2017: $7.96 per share | Fiscal year 2016: $6.41 per share | Fiscal year 2015: $5.23 per share | Fiscal year 2014: $0.93 per share | Fiscal year 2013: $3.51 per share | Fiscal year 2012: $4.79 per share | Fiscal year 2011: $2.67 per share | Fiscal year 2010: $0.83 per share | Fiscal year 2009: $0.23 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026